Cargando…

Pigment Epithelium-Derived Factor: Inhibition of Phosphorylation of Insulin Receptor (IR)/IR Substrate (IRS), Osteogeneration from Adipocytes, and Increased Levels Due to Doxorubicin Exposure

Objectives: Pigment epithelium-derived factor (PEDF) has been recently linked to insulin resistance and is capable of differentiating myocytes to bone. We examined in more detail the intricate signalling of the insulin pathway influenced by PEDF in skeletal myocytes. We tested whether this serpin is...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Isobel C., Carnagarin, Revathy, Armstrong, Jo, Lin, Daphne P. L., Baxter-Holland, Mia, Elahy, Mina, Dass, Crispin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384968/
https://www.ncbi.nlm.nih.gov/pubmed/37514146
http://dx.doi.org/10.3390/pharmaceutics15071960
_version_ 1785081288291516416
author Jones, Isobel C.
Carnagarin, Revathy
Armstrong, Jo
Lin, Daphne P. L.
Baxter-Holland, Mia
Elahy, Mina
Dass, Crispin R.
author_facet Jones, Isobel C.
Carnagarin, Revathy
Armstrong, Jo
Lin, Daphne P. L.
Baxter-Holland, Mia
Elahy, Mina
Dass, Crispin R.
author_sort Jones, Isobel C.
collection PubMed
description Objectives: Pigment epithelium-derived factor (PEDF) has been recently linked to insulin resistance and is capable of differentiating myocytes to bone. We examined in more detail the intricate signalling of the insulin pathway influenced by PEDF in skeletal myocytes. We tested whether this serpin is also capable of generating de novo bone from adipocytes in vitro and in vivo, and how the anticancer drug doxorubicin links with PEDF and cellular metabolism. Methods and key findings: We demonstrate that PEDF can inhibit phosphorylation of insulin receptor (IR) and insulin receptor substrate (IRS) in skeletal myocytes. PEDF constitutively activates p42/44 MAPK/Erk, but paradoxically does not affect mitogenic signalling. PEDF did not perturb either mitochondrial activity or proliferation in cells representing mesenchymal stem cells, cardiomyocytes, and skeletal myocytes and adipocytes. PEDF induced transdifferentiation of adipocytes to osteoblasts, promoting bone formation in cultured adipocytes in vitro and gelfoam fatpad implants in vivo. Bone formation in white adipose tissue (WAT) was better than in brown adipose tissue (BAT). The frontline anticancer drug doxorubicin increased levels of PEDF in a human breast cancer cell line, mirroring the in vivo finding where cardiac muscle tissue was stained increasingly for PEDF as the dose of doxorubicin increased in mice. PEDF also increased levels of reactive oxygen species (ROS) and glutathione (GSH) in the breast cancer cell line. Conclusions: PEDF may be used to regenerate bone from adipose tissue in cases of trauma such as fractures or bone cancers. The increased presence of PEDF in doxorubicin-treated tumour cells need further exploration, and could be useful therapeutically in future. The safety of PEDF administration in vivo was further demonstrated in this study.
format Online
Article
Text
id pubmed-10384968
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103849682023-07-30 Pigment Epithelium-Derived Factor: Inhibition of Phosphorylation of Insulin Receptor (IR)/IR Substrate (IRS), Osteogeneration from Adipocytes, and Increased Levels Due to Doxorubicin Exposure Jones, Isobel C. Carnagarin, Revathy Armstrong, Jo Lin, Daphne P. L. Baxter-Holland, Mia Elahy, Mina Dass, Crispin R. Pharmaceutics Article Objectives: Pigment epithelium-derived factor (PEDF) has been recently linked to insulin resistance and is capable of differentiating myocytes to bone. We examined in more detail the intricate signalling of the insulin pathway influenced by PEDF in skeletal myocytes. We tested whether this serpin is also capable of generating de novo bone from adipocytes in vitro and in vivo, and how the anticancer drug doxorubicin links with PEDF and cellular metabolism. Methods and key findings: We demonstrate that PEDF can inhibit phosphorylation of insulin receptor (IR) and insulin receptor substrate (IRS) in skeletal myocytes. PEDF constitutively activates p42/44 MAPK/Erk, but paradoxically does not affect mitogenic signalling. PEDF did not perturb either mitochondrial activity or proliferation in cells representing mesenchymal stem cells, cardiomyocytes, and skeletal myocytes and adipocytes. PEDF induced transdifferentiation of adipocytes to osteoblasts, promoting bone formation in cultured adipocytes in vitro and gelfoam fatpad implants in vivo. Bone formation in white adipose tissue (WAT) was better than in brown adipose tissue (BAT). The frontline anticancer drug doxorubicin increased levels of PEDF in a human breast cancer cell line, mirroring the in vivo finding where cardiac muscle tissue was stained increasingly for PEDF as the dose of doxorubicin increased in mice. PEDF also increased levels of reactive oxygen species (ROS) and glutathione (GSH) in the breast cancer cell line. Conclusions: PEDF may be used to regenerate bone from adipose tissue in cases of trauma such as fractures or bone cancers. The increased presence of PEDF in doxorubicin-treated tumour cells need further exploration, and could be useful therapeutically in future. The safety of PEDF administration in vivo was further demonstrated in this study. MDPI 2023-07-15 /pmc/articles/PMC10384968/ /pubmed/37514146 http://dx.doi.org/10.3390/pharmaceutics15071960 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jones, Isobel C.
Carnagarin, Revathy
Armstrong, Jo
Lin, Daphne P. L.
Baxter-Holland, Mia
Elahy, Mina
Dass, Crispin R.
Pigment Epithelium-Derived Factor: Inhibition of Phosphorylation of Insulin Receptor (IR)/IR Substrate (IRS), Osteogeneration from Adipocytes, and Increased Levels Due to Doxorubicin Exposure
title Pigment Epithelium-Derived Factor: Inhibition of Phosphorylation of Insulin Receptor (IR)/IR Substrate (IRS), Osteogeneration from Adipocytes, and Increased Levels Due to Doxorubicin Exposure
title_full Pigment Epithelium-Derived Factor: Inhibition of Phosphorylation of Insulin Receptor (IR)/IR Substrate (IRS), Osteogeneration from Adipocytes, and Increased Levels Due to Doxorubicin Exposure
title_fullStr Pigment Epithelium-Derived Factor: Inhibition of Phosphorylation of Insulin Receptor (IR)/IR Substrate (IRS), Osteogeneration from Adipocytes, and Increased Levels Due to Doxorubicin Exposure
title_full_unstemmed Pigment Epithelium-Derived Factor: Inhibition of Phosphorylation of Insulin Receptor (IR)/IR Substrate (IRS), Osteogeneration from Adipocytes, and Increased Levels Due to Doxorubicin Exposure
title_short Pigment Epithelium-Derived Factor: Inhibition of Phosphorylation of Insulin Receptor (IR)/IR Substrate (IRS), Osteogeneration from Adipocytes, and Increased Levels Due to Doxorubicin Exposure
title_sort pigment epithelium-derived factor: inhibition of phosphorylation of insulin receptor (ir)/ir substrate (irs), osteogeneration from adipocytes, and increased levels due to doxorubicin exposure
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384968/
https://www.ncbi.nlm.nih.gov/pubmed/37514146
http://dx.doi.org/10.3390/pharmaceutics15071960
work_keys_str_mv AT jonesisobelc pigmentepitheliumderivedfactorinhibitionofphosphorylationofinsulinreceptoririrsubstrateirsosteogenerationfromadipocytesandincreasedlevelsduetodoxorubicinexposure
AT carnagarinrevathy pigmentepitheliumderivedfactorinhibitionofphosphorylationofinsulinreceptoririrsubstrateirsosteogenerationfromadipocytesandincreasedlevelsduetodoxorubicinexposure
AT armstrongjo pigmentepitheliumderivedfactorinhibitionofphosphorylationofinsulinreceptoririrsubstrateirsosteogenerationfromadipocytesandincreasedlevelsduetodoxorubicinexposure
AT lindaphnepl pigmentepitheliumderivedfactorinhibitionofphosphorylationofinsulinreceptoririrsubstrateirsosteogenerationfromadipocytesandincreasedlevelsduetodoxorubicinexposure
AT baxterhollandmia pigmentepitheliumderivedfactorinhibitionofphosphorylationofinsulinreceptoririrsubstrateirsosteogenerationfromadipocytesandincreasedlevelsduetodoxorubicinexposure
AT elahymina pigmentepitheliumderivedfactorinhibitionofphosphorylationofinsulinreceptoririrsubstrateirsosteogenerationfromadipocytesandincreasedlevelsduetodoxorubicinexposure
AT dasscrispinr pigmentepitheliumderivedfactorinhibitionofphosphorylationofinsulinreceptoririrsubstrateirsosteogenerationfromadipocytesandincreasedlevelsduetodoxorubicinexposure